A prospective, single-blind, randomized, phase III study to evaluate the safety and efficacy of Fibrin Sealant Grifols as an adjunct to hemostasis compared with manual compression in vascular surgery
journal contribution
posted on 2023-06-09, 04:32authored byDragoslav Nenezic, Jaume Ayguasanosa, Gabor Menyhei, Holjencsik Tamas, Lajos Matyas, Satish Muluk, Kecia Courtney, Julia Ibanez, Junliang Chen, Alvaro Segura-Vasi, German Sokurenko, Anil Paramesh, Harold Minkowitz, Igor Sonkin, Brajesh Lal, Daniel Ihnat, Benjamin Brooke, Vladan Popovic, Mohammad Eslami, Alik Farber, Sibu Saha, Stuart Greenstein, Andrey Karpenko, Ivan Katelnitskiy, Tran Nam, John Hoch, Ali Amin, Paul White, Ravi R Rajani, Joseph GriffinJoseph Griffin, Albert Yurvati, John Matsuura, Jordi Navarro-Puerto, Gladis Barrera, Carrie Hames, Valerie Lloyd, Yanmei Zhang, Jiang Lin, Henry Li, Deborah Covington, Waleska Henriquez, Carmen Soucheiron, Susan Beck, Roma Casamiquela
A prospective, single-blind, randomized, phase III study to evaluate the safety and efficacy of Fibrin Sealant Grifols as an adjunct to hemostasis compared with manual compression in vascular surgery